BR9708161A - Peptídeos com aumentada afinidade de ligação para moléculas hla - Google Patents

Peptídeos com aumentada afinidade de ligação para moléculas hla

Info

Publication number
BR9708161A
BR9708161A BR9708161A BR9708161A BR9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A
Authority
BR
Brazil
Prior art keywords
peptides
binding affinity
increased binding
hla molecules
hla
Prior art date
Application number
BR9708161A
Other languages
English (en)
Inventor
Alessandro Sette
Robert W Chestnut
John Sidney
Original Assignee
Epimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimmune Inc filed Critical Epimmune Inc
Publication of BR9708161A publication Critical patent/BR9708161A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9708161A 1996-03-11 1997-03-10 Peptídeos com aumentada afinidade de ligação para moléculas hla BR9708161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1311396P 1996-03-11 1996-03-11
PCT/US1997/003778 WO1997033602A1 (en) 1996-03-11 1997-03-10 Peptides with increased binding affinity for hla molecules

Publications (1)

Publication Number Publication Date
BR9708161A true BR9708161A (pt) 1999-07-27

Family

ID=21758378

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708161A BR9708161A (pt) 1996-03-11 1997-03-10 Peptídeos com aumentada afinidade de ligação para moléculas hla

Country Status (9)

Country Link
EP (1) EP0914142B9 (pt)
JP (2) JP2001504799A (pt)
CN (1) CN1225590A (pt)
AT (1) ATE511849T1 (pt)
AU (1) AU2203797A (pt)
BR (1) BR9708161A (pt)
CA (1) CA2248657A1 (pt)
ES (1) ES2367640T3 (pt)
WO (1) WO1997033602A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
US6183746B1 (en) 1997-10-09 2001-02-06 Zycos Inc. Immunogenic peptides from the HPV E7 protein
CA2323632A1 (en) * 1998-03-13 1999-09-16 Epimmune Inc. Hla-binding peptides and their uses
WO2000044775A2 (en) * 1999-01-27 2000-08-03 Epimmune Inc. Identification of broadly reactive hla restricted t cell epitopes
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
AU1661201A (en) * 1999-11-18 2001-05-30 Epimmune, Inc. Heteroclitic analogs and related methods
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
ATE429643T1 (de) 2000-07-12 2009-05-15 Agensys Inc Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann
EP1313850B1 (en) 2000-08-28 2008-08-06 Agensys, Inc. Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
AU2002246708A1 (en) 2000-12-15 2002-08-12 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
IL158860A0 (en) * 2001-05-15 2004-05-12 Agensys Inc Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
AU2002322009A1 (en) 2001-05-18 2002-12-03 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
WO2003022995A2 (en) 2001-09-06 2003-03-20 Agensys, Inc. Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
CA2481462A1 (en) * 2002-04-05 2003-10-23 Epimmune Inc. Heteroclitic analogs and related methods
EP1539215A2 (en) * 2002-06-25 2005-06-15 City of Hope Adjuvant-free peptide vaccine
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
CA2503346C (en) 2002-11-27 2014-03-18 Agensys, Inc. Nucleic acid and corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
AU2004210975B2 (en) 2003-02-10 2008-04-10 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
DK1629088T3 (da) 2003-05-30 2012-05-07 Agensys Inc Varianter af prostatastamcelleantigen (psca) og undersekvenser deraf
MXPA06013834A (es) 2004-05-28 2007-03-01 Agensys Inc Anticuerpos y moleculas relacionadas que enlazan a proteinas psca.
EP1863848A4 (en) 2005-03-31 2009-09-23 Agensys Inc CORRESPONDING ANTIBODIES AND MOLECULES THAT ATTACH PROTEINS 161P2F10B
WO2007083807A1 (ja) * 2006-01-23 2007-07-26 Green Peptide Co., Ltd. Ｃ型肝炎ウイルス由来ペプチド
US20090023895A1 (en) 2006-02-07 2009-01-22 Nec Corporation Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide
EP2434014B1 (en) 2006-10-12 2014-12-10 Nec Corporation HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
EP3085707B1 (en) 2007-11-01 2019-02-27 Mayo Foundation for Medical Education and Research Hla-dr binding peptides and their uses
EP2391635B1 (en) 2009-01-28 2017-04-26 Epimmune Inc. Pan-dr binding polypeptides and uses thereof
AU2012258603A1 (en) 2011-05-26 2014-01-16 Geneius Biotechnology, Inc. Modulated immunodominance therapy
SG11201907524UA (en) 2017-03-03 2019-09-27 Treos Bio Zrt Peptide vaccines
EP3846845A1 (en) 2018-09-04 2021-07-14 Treos Bio Limited Peptide vaccines
US11421015B2 (en) 2020-12-07 2022-08-23 Think Therapeutics, Inc. Method of compact peptide vaccines using residue optimization
US11161892B1 (en) 2020-12-07 2021-11-02 Think Therapeutics, Inc. Method of compact peptide vaccines using residue optimization
US11058751B1 (en) 2020-11-20 2021-07-13 Think Therapeutics, Inc. Compositions for optimized RAS peptide vaccines
US11464842B1 (en) 2021-04-28 2022-10-11 Think Therapeutics, Inc. Compositions and method for optimized peptide vaccines using residue optimization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200320A (en) * 1987-12-07 1993-04-06 National Jewish Center For Immunology And Respiratory Medicine Method for identifying useful polypeptide vaccines
IL106610A0 (en) * 1992-08-07 1993-12-08 Cytel Corp Hla binding peptides and their uses
US20050271676A1 (en) * 1993-03-05 2005-12-08 Epimmune Inc. Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
JP3650110B2 (ja) * 1993-08-02 2005-05-18 ザ スクリップス リサーチ インスティテュート Ｂ型肝炎ウイルスに対する細胞毒性ｔリンパ球応答を誘発するためのペプチド
WO1995011255A1 (fr) * 1993-10-19 1995-04-27 Ajinomoto Co., Inc. Peptide pouvant induire une reponse immune contre vih et agent contenant ce peptide pour la prevention ou le traitement du sida

Also Published As

Publication number Publication date
EP0914142A4 (en) 2004-06-23
EP0914142B1 (en) 2011-06-08
AU2203797A (en) 1997-10-01
EP0914142A1 (en) 1999-05-12
CA2248657A1 (en) 1997-09-18
JP2009108097A (ja) 2009-05-21
ES2367640T3 (es) 2011-11-07
ATE511849T1 (de) 2011-06-15
CN1225590A (zh) 1999-08-11
EP0914142B9 (en) 2012-01-04
WO1997033602A1 (en) 1997-09-18
JP2001504799A (ja) 2001-04-10

Similar Documents

Publication Publication Date Title
BR9708161A (pt) Peptídeos com aumentada afinidade de ligação para moléculas hla
DE69711083D1 (de) Kontaktstift für prüfzwecke
DE69729829D1 (de) Zusammensetzung für Wasser-enthaltende Dispersion
WO1999015658A3 (en) Human regulatory molecules
DE69818157D1 (de) Instrument für Eingriffe am Uterus
DE69017300D1 (de) Nager mit geringem Verschleiss für chirurgischen Retraktor.
ATE424560T1 (de) Marker für neuromyelitis optica
ATE346922T1 (de) Domäne 1 beta2-gpi polypetiden und deren diagnostische und therepeutische verwendungen
DE69005530D1 (de) Lüfteranordnung für Wechselstromfahrzeuggenerator.
DE69805905D1 (de) Testeinheit zur Prüfung von Steckverbindern
BR9804676A (pt) Processo para o teste de um dispositivo de embreagem automatizado.
DE19780486T1 (de) Druck-Zug-Ventilanordnung für einen Motorzylinder
DE69721506D1 (de) Betriebsverfahren für eine ionenfalle
DE69625833D1 (de) Testkarte für Analysen
ATE404208T1 (de) Uridin-therapie für patienten mit erhöhten purin- werten
DE59005619D1 (de) Rollenprüfstand zur kombinierten Leistungs- und Bremsenprüfung an Kraftfahrzeugen.
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
BR9808729A (pt) Processo para a preparação de um anti-oxidante
PT801179E (pt) Dispositivo para controlo da valvula de um autoclismo
NO900052L (no) Fremgangsmaate for betjening av en oljebroenn til havs.
PT789591E (pt) Metodo para identificar individuos que sofram de uma anomalia celular
AR019572A1 (es) Procedimiento de adsorcion para la desaromatizacion de hidrocarburos.
FR2720515B1 (fr) Instrument spatial d'observation laser, et véhicule spatial le comportant.
KR980004550U (ko) 오일 펌프 시험장치
BR9916540B1 (pt) agulha para aparelho indicador de veìculo automóvel, e, indicador.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , 7A , 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006.